These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21536661)

  • 1. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
    Felip E; Gridelli C; Baas P; Rosell R; Stahel R;
    Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
    Stahel R; Thatcher N; Früh M; Le Péchoux C; Postmus PE; Sorensen JB; Felip E;
    Ann Oncol; 2011 Sep; 22(9):1973-1980. PubMed ID: 21727198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.
    Besse B; Adjei A; Baas P; Meldgaard P; Nicolson M; Paz-Ares L; Reck M; Smit EF; Syrigos K; Stahel R; Felip E; Peters S; ;
    Ann Oncol; 2014 Aug; 25(8):1475-84. PubMed ID: 24669016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.
    Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Sep; 25(9):1681-1690. PubMed ID: 24718890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: ESMO Consensus Conference Guidelines 2012.
    Horwich A; Hugosson J; de Reijke T; Wiegel T; Fizazi K; Kataja V; ;
    Ann Oncol; 2013 May; 24(5):1141-62. PubMed ID: 23303340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
    Passaro A; Leighl N; Blackhall F; Popat S; Kerr K; Ahn MJ; Arcila ME; Arrieta O; Planchard D; de Marinis F; Dingemans AM; Dziadziuszko R; Faivre-Finn C; Feldman J; Felip E; Curigliano G; Herbst R; Jänne PA; John T; Mitsudomi T; Mok T; Normanno N; Paz-Ares L; Ramalingam S; Sequist L; Vansteenkiste J; Wistuba II; Wolf J; Wu YL; Yang SR; Yang JCH; Yatabe Y; Pentheroudakis G; Peters S
    Ann Oncol; 2022 May; 33(5):466-487. PubMed ID: 35176458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
    Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Radiother Oncol; 2015 Dec; 117(3):559-81. PubMed ID: 26683800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
    Colombo N; Sessa C; Bois AD; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31048403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
    Honecker F; Aparicio J; Berney D; Beyer J; Bokemeyer C; Cathomas R; Clarke N; Cohn-Cedermark G; Daugaard G; Dieckmann KP; Fizazi K; Fosså S; Germa-Lluch JR; Giannatempo P; Gietema JA; Gillessen S; Haugnes HS; Heidenreich A; Hemminki K; Huddart R; Jewett MAS; Joly F; Lauritsen J; Lorch A; Necchi A; Nicolai N; Oing C; Oldenburg J; Ondruš D; Papachristofilou A; Powles T; Sohaib A; Ståhl O; Tandstad T; Toner G; Horwich A
    Ann Oncol; 2018 Aug; 29(8):1658-1686. PubMed ID: 30113631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
    Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
    Brahmer JR; Govindan R; Anders RA; Antonia SJ; Sagorsky S; Davies MJ; Dubinett SM; Ferris A; Gandhi L; Garon EB; Hellmann MD; Hirsch FR; Malik S; Neal JW; Papadimitrakopoulou VA; Rimm DL; Schwartz LH; Sepesi B; Yeap BY; Rizvi NA; Herbst RS
    J Immunother Cancer; 2018 Jul; 6(1):75. PubMed ID: 30012210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.
    Hutchings M; Ladetto M; Buske C; de Nully Brown P; Ferreri AJM; Pfreundschuh M; Schmitz N; Balari AS; van Imhoff G; Walewski J;
    Ann Oncol; 2018 Aug; 29(8):1687-1700. PubMed ID: 29924296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Int J Gynecol Cancer; 2016 Jan; 26(1):2-30. PubMed ID: 26645990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
    Keilholz U; Ascierto PA; Dummer R; Robert C; Lorigan P; van Akkooi A; Arance A; Blank CU; Chiarion Sileni V; Donia M; Faries MB; Gaudy-Marqueste C; Gogas H; Grob JJ; Guckenberger M; Haanen J; Hayes AJ; Hoeller C; Lebbé C; Lugowska I; Mandalà M; Márquez-Rodas I; Nathan P; Neyns B; Olofsson Bagge R; Puig S; Rutkowski P; Schilling B; Sondak VK; Tawbi H; Testori A; Michielin O
    Ann Oncol; 2020 Nov; 31(11):1435-1448. PubMed ID: 32763453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.
    Buske C; Hutchings M; Ladetto M; Goede V; Mey U; Soubeyran P; Spina M; Stauder R; Trněný M; Wedding U; Fields P;
    Ann Oncol; 2018 Mar; 29(3):544-562. PubMed ID: 29194473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.
    Michielin O; van Akkooi A; Lorigan P; Ascierto PA; Dummer R; Robert C; Arance A; Blank CU; Chiarion Sileni V; Donia M; Faries MB; Gaudy-Marqueste C; Gogas H; Grob JJ; Guckenberger M; Haanen J; Hayes AJ; Hoeller C; Lebbé C; Lugowska I; Mandalà M; Márquez-Rodas I; Nathan P; Neyns B; Olofsson Bagge R; Puig S; Rutkowski P; Schilling B; Sondak VK; Tawbi H; Testori A; Keilholz U
    Ann Oncol; 2020 Nov; 31(11):1449-1461. PubMed ID: 32763452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line.
    ; ; ;
    Indian J Cancer; 2017; 54(1):89-103. PubMed ID: 29199671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.